These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 11594001

  • 1. Renin-angiotensin system inhibitors--implications in the metabolism of the reactive oxygen species.
    Ianosi-Irimie M, Deutsch P, Deutsch G.
    Pharmazie; 2001 Sep; 56(9):748-9. PubMed ID: 11594001
    [No Abstract] [Full Text] [Related]

  • 2. [Beta adrenergic receptor-induced stimulation of the vascular renin-angiotensin system: significance for noradrenaline liberation and the mechanism of action of angiotensin-converting enzyme inhibitors].
    Göthert M.
    Z Kardiol; 1988 Sep; 77 Suppl 3():35-7. PubMed ID: 2850686
    [No Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system inhibitors as antihypertrophic agents.
    Ianosi-Irimie M, Deutsch P.
    Pharmazie; 2000 Aug; 55(8):629. PubMed ID: 10989849
    [No Abstract] [Full Text] [Related]

  • 4. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
    Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL.
    Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
    [Abstract] [Full Text] [Related]

  • 5. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K, Ortmann M, Salguero G, Doerries C, Landmesser U, Luchtefeld M, Brandes RP, Gwinner W, Tschernig T, Brabant EG, Klos A, Schaefer A, Drexler H, Schieffer B.
    Cardiovasc Res; 2006 Aug 01; 71(3):596-605. PubMed ID: 16843452
    [Abstract] [Full Text] [Related]

  • 6. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 01; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 7. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ, Waanders F, Rops AL, Kramer AB, van Goor H, Berden JH, Navis G, van der Vlag J.
    Nephrol Dial Transplant; 2009 Sep 01; 24(9):2637-45. PubMed ID: 19429930
    [Abstract] [Full Text] [Related]

  • 8. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K, Fujii K, Kansui Y, Iida M.
    Clin Exp Pharmacol Physiol; 2004 Sep 01; 31(9):650-5. PubMed ID: 15479174
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug 01; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 10. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 01; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 11. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar 01; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 12. Activation of the renin angiotensin system in short aortic cross-clamp times.
    George JE, Joob AW, Flanagan TL, Kron IL.
    Curr Surg; 1988 Mar 01; 45(1):7-9. PubMed ID: 2831013
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC, Perazella MA.
    Am J Med; 2004 Feb 15; 116(4):263-72. PubMed ID: 14969655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
    Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E.
    Am J Nephrol; 2009 Feb 15; 29(6):582-91. PubMed ID: 19145073
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
    Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, Nickenig G.
    Circ Res; 2004 Mar 05; 94(4):534-41. PubMed ID: 14699015
    [Abstract] [Full Text] [Related]

  • 20. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR, Lopes KL, Carillo BA, Bergamaschi CT, Carmona AK, Casarini DE, Furukawa L, Heimann JC, Campos RR, Dolnikoff MS.
    Am J Hypertens; 2007 Jun 05; 20(6):692-8. PubMed ID: 17531930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.